CIDP Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

RWE-based Treatment Patterns and Outcomes in CIDP
Conditions:   Chronic Inflammatory Demyelinating Polyneuropathy;   Guillain-Barre Syndrome;   Hereditary Amyloidosis Intervention:   Other: No intervention. Retrospective observation only. Sponsors:   RwHealth;   Alnylam Pharmaceuticals;   Northern Care Alliance NHS Foundation Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials

A Proof of Concept Study With Rituximab in Patients With CIDP Not Responding to Conventional Immune Therapy
Condition:   Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Intervention:   Drug: Rituximab Sponsor:   Istituto Clinico Humanitas Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2023 Category: Research Source Type: clinical trials